E1381. Chemotherapy-Induced Toxicities: An Imaging Primer
Authors
Natasha Larocque;
McMaster University
Nikhil Patil;
McMaster University
Christian van der Pol;
McMaster University
Carlos Torres;
University of Ottawa
Demetrios Raptis;
Washington University School of Medicine
Michael Patlas;
McMaster University
Background
The Coronavirus Disease of 2019 (COVID-19) pandemic caused significant delays in the delivery of cancer treatments. As cancer treatment and imaging volumes return to normal, radiologists will encounter more cases of chemotherapy-induced toxicities. These toxicities have varied appearances on imaging and can affect multiple organ systems. Furthermore, novel chemotherapy agents, such as immune checkpoint inhibitors and monoclonal antibodies, can cause complications not previously seen with traditional chemotherapy agents. The purpose of this educational exhibit is to offer a unified resource for general radiologists and trainees regarding the varied imaging appearances of chemotherapy-induced toxicities.
Educational Goals / Teaching Points
To review the possible imaging appearances of chemotherapy-induced toxicities using a head-to-toe approach.
Conclusion
Chemotherapy-related toxicities have manifestations across many organ systems. Knowledge of medication history is key in making a diagnosis of chemotherapy-related toxicity as other differentials include disease progression or infection.